10.1002/chem.201604456
Chemistry - A European Journal
FULL PAPER
(CH3;acac), 16.6 (CH3;acac), 14.1 (CH3), 12.7 (CH3) ppm. 195Pt-NMR (65
MHz, 25 °C, CDCl3): δ -3314 ppm. MS (ESI+, m/z, fragment): 497.2
(M+H)+. Anal. Calc. for C17H19NO2PtS: C, 41.13; H, 3.86; N, 2.82; S,
6.45%. Found: C, 40.85; H, 3.82; N, 2.92; S, 6.81%.
According to the General Procedure B 20 ml of dry 1,4-dioxane were
added to
a
mixture of 268 mg (0.8 mmol) N-phenyl-4,5-
dimethylthiazolium salt 1 and 102 mg of Ag2O (0.44 mmol, 0.55 eq.).
Stepwise addition of 299 mg Pt(COD)Cl2 (0.8 mmol, 1 eq.), 732 mg of
1,3-diphenylpropane-1,3-dione (6) (3.2 mmol, 4.0 eq.) and 359 mg of
KOtBu (3.2 mmol, 4.0 eq.) and following General Procedure B in
temperature and workup steps yielded complex 13 as a bright orange
powder (146 mg, 30.0 %). M.p.: dec. >314 °C. 1H-NMR (CDCl3, 25 °C,
300 MHz): δ 8.12 (d, J = 7.9 Hz, 4H, CHarom), 8.07–7.96 (m, 1H, CHarom),
7.58–7.40 (m, 7H, CHarom), 7.21–7.01 (m, 2H, CHarom), 6.84 (s, 1H,
CHacac), 2.73 (s, 3H, CH3), 2.32 (s, 3H, CH3) ppm. 13C-NMR (CDCl3,
25 °C, 75 MHz): δ 180.1 (CO), 180.0 (CO), 177.8 (NCS), 140.1 (2C, Ci),
137.1 (Ci), 132.9 (CHarom), 130.9 (CHarom), 130.8 (CHarom), 128.9 (CHarom),
128.7 (CHarom), 128.5 (3C, CHarom), 127.9 (Ci), 127.3 (3C, CHarom), 127.2
(Ci), 125.7 (CHarom), 123.6 (CHarom), 113.5 (CHarom), 96.7 (CHarom), 14.2
(CH3), 12.8 (CH3) ppm. 195Pt-NMR (65 MHz, 25 °C, CDCl3): δ -3293 ppm.
MS (ESI+, m/z, fragment): 607.2 (M+H)+. Anal. Calc. for C26H21NO2PtS: C,
51.48; H, 3.49; N, 2.31; S, 5.29%. Found: C, 51.34; H, 3.32; N, 2.38; S,
5.38%.
(SP-4-4)-[4,5-dimethyl-3-phenyl-κC’-1,3-thiazol-2-ylidene-κC]-[3-
phenylpentane-2,4-dionato-κO,κO’] platinum(II) (10). According to the
General Procedure A 20 ml of dry DMF were added to a mixture of 268
mg (0.8 mmol) N-phenyl-4,5-dimethylthiazolium salt 1 and 102 mg of
Ag2O (0.44 mmol, 0.55 eq.). Stepwise addition of 299 mg Pt(COD)Cl2
(0.8 mmol, 1 eq.), 564 mg of 3-phenylpentane-2,4-dione (3) (3.2 mmol,
4.0 eq.), 359 mg of KOtBu (3.2 mmol, 4.0 eq.) and following General
Procedure A in temperature and workup steps yielded complex 10 as a
yellow powder (75 mg, 16.8 %). M.p.: 260 °C. 1H-NMR (CDCl3, 25 °C,
500 MHz): δ 7.99–7.79 (m, 1H, CHarom), 7.47–7.33 (m, 3H, CHarom), 7.33–
7.27 (m, 1H, CHarom), 7.24–7.17 (m, 2H, CHarom), 7.16–7.00 (m, 2H,
CHarom), 2.70 (s, 3H, CH3), 2.28 (s, 3H, CH3), 1.83 (s, 3H, CH3), 1.79 (s,
3H, CH3) ppm. 13C-NMR (CDCl3, 25 °C, 125 MHz): δ 185.3 (CO), 184.1
(CO), 177.9 (NCS), 151.4 (Ci-Pt), 141.7 (Ci), 137.0 (Ci), 132.5 (CHarom),
131.9 (2C, CHarom), 128.8 (2C, CHarom), 128.1 (Ci), 126.7 (CHarom), 125.5
(CHarom.), 123.6 (Ci), 123.4 (CHarom), 117.4 (Ci), 113.4 (CHarom.), 29.1
(CH3;acac), 28.9 (CH3;acac), 14.1 (CH3), 12.7 (CH3) ppm. 195Pt-NMR (65
MHz, 25 °C, CDCl3): δ -3331 ppm. MS (ESI+, m/z, fragment): 559.3
(M+H)+. Anal. Calc. for C22H21NO2PtS: C, 47.31; H, 3.79; N, 2.52; S,
5.74%. Found: C, 47.69; H, 3.53; N, 2.54; S, 5.97%.
(SP-4-4)-[4,5-dimethyl-3-phenyl-κC’-1,3-thiazol-2-ylidene-κC]-[1,3-
bis(2,4,6-trimethylphenyl)propane-1,3-dionato-κO,κO’]platinum(II)
(14). According to the General Procedure A 20 ml of dry DMF were
added to
a
mixture of 1262 mg (3.2 mmol) N-phenyl-4,5-
dimethylthiazolium salt 1 and 408 mg of Ag2O (1.76 mmol, 0.55 eq.).
Stepwise addition of 1196 mg Pt(COD)Cl2 (3.2 mmol, 1 eq.), 3.95 g 1,3-
bis(2,4,6-trimethylphenyl)propane-1,3-dione (7) (12.8 mmol, 4.0 eq.),
1.48 g of KOtBu (12.8 mmol, 4.0 eq.) and following General Procedure A
in temperature and workup steps yielded complex 14 as a yellow powder
(874 mg, 39.5 %). According to the General Procedure B 20 ml of dry
1,4-dioxane were added to a mixture of 268 mg (0.8 mmol) N-phenyl-4,5-
dimethylthiazolium salt 1 and 102 mg of Ag2O (0.44 mmol, 0.55 eq.).
Stepwise addition of 299 mg Pt(COD)Cl2 (0.8 mmol, 1 eq.), 987 mg of
1,3-bis(2,4,6-trimethylphenyl)propane-1,3-dione (3.2 mmol, 4.0 eq.) and
359 mg of KOtBu (3.2 mmol, 4.0 eq.) and following General Procedure B
in temperature and workup steps yielded complex 14 as a bright yellow
powder (226 mg, 40.8 %). M.p.: 307-308 °C. 1H-NMR (CDCl3, 25 °C, 300
MHz): δ 7.97–7.65 (m, 1H, CHarom), 7.40 (dd, J = 5.9 Hz, J = 3.4 Hz, 1H,
CHarom), 7.02 (dd, J = 5.8 Hz, J = 3.3 Hz, 2H, CHarom), 6.91–6.80 (m, 4H,
CHarom), 5.68 (s, 1H, CHacac), 2.69 (s, 3H, CH3), 2.42–2.33 (m, 12H),
2.33–2.27 (m, 6H), 2.27–2.18 (m, 3H) ppm. 13C-NMR (CDCl3, 25 °C, 125
MHz): δ 185.8 (CO), 184.8 (CO), 177.7 (NCS), 151.4 (Ci-Pt), 139.3 (2C,
Ci), 137.6 (Ci), 137.6 (Ci), 136.9 (Ci), 134.2 (2C, Ci), 134.1 (2C, Ci), 133.0
(2C, CHarom), 128.2 (CHarom), 128.1 (CHarom), 127.4 (Ci), 125.6 (CHarom),
123.9 (2C, Ci), 123.6 (CHarom), 113.4 (CHarom), 107.5 (CHarom), 21.1 (2C,
CH3), 20.0 (2C, CH3), 19.9 (2C, CH3), 14.1 (CH3), 12.7 (CH3) ppm. 195Pt-
NMR (65 MHz, 25 °C, CDCl3): δ -3296 ppm. MS (ESI+, m/z, fragment):
691.5 (M+H)+. Anal. Calc. for C32H33NO2PtS: C, 55.64; H, 4.82; N, 2.03;
S, 4.64%. Found: C, 55.83; H, 4.91; N, 2.06; S, 4.50%.
(SP-4-4)-[4,5-dimethyl-3-phenyl-κC’-1,3-thiazol-2-ylidene-κC]-
[1,1,1,5,5,5-hexafluoropentane-2,4-dionato-κO,κO’] platinum(II) (11).
According to the General Procedure A 20 ml of dry DMF were added to a
mixture of 268 mg (0.8 mmol) N-phenyl-4,5-dimethylthiazolium salt 1 and
102 mg of Ag2O (0.44 mmol, 0.55 eq.). Stepwise addition of 299 mg
Pt(COD)Cl2 (0.8 mmol, 1 eq.), 666 mg of 1,1,1,5,5,5-hexafluoropentane-
2,4-dione (4) (3.2 mmol, 4.0 eq.), 359 mg of KOtBu (3.2 mmol, 4.0 eq.)
and following General Procedure A in temperature and workup steps
yielded complex 11 as an orange powder (44 mg, 9.3 %). M.p.: 238-
241 °C. 1H-NMR (CDCl3, 25 °C, 600 MHz): δ 7.63–7.45 (m, 1H, CHarom),
7.36–7.26 (m, 1H, CHarom), 7.08–6.96 (m, 2H, CHarom), 6.20 (s, 1H,
CHacac), 2.63 (s, 3H, CH3), 2.25 (s, 3H, CH3) ppm. 13C-NMR (CDCl3,
25 °C, 151 MHz): δ 172.5 (CO), 172.4 (CO), 171.7 (NCS), 150.9 (Ci-Pt),
137.3 (Ci), 132.6 (CHarom), 125.8 (CHarom), 125.2 (Ci), 124.5 (CHarom),
123.8 (Ci), 119.3 (Ci), 117.2 (Ci), 113.8 (CHarom), 93.8 (CHarom), 14.0
(CH3), 12.5 (CH3) ppm. 19F-NMR (DMSO, 25 °C, 284 MHz): δ -76.0, -
75.8 (CF3) ppm. 195Pt-NMR (65 MHz, 25 °C, CDCl3): δ -3307 ppm. MS
(ESI+, m/z, fragment): 591.1 (M+H)+. Anal. Calc. for C16H11F6NO2PtS: C,
32.55; H, 1.88; N, 2.37; S, 5.43%. Found: C, 32.39; H, 1.84; N, 2.43; S,
5.60%.
(SP-4-4)-[4,5-dimethyl-3-phenyl-κC’-1,3-thiazol-2-ylidene-κC]-
[2,2,6,6-tetramethylheptane-3,5-dionato-κO,κO’]platinum(II)
(12).
According to the General Procedure A 20 ml of dry DMF were added to a
mixture of 268 mg (0.8 mmol) N-phenyl-4,5-dimethylthiazolium salt 1 and
102 mg of Ag2O (0.44 mmol, 0.55 eq.). Stepwise addition of 299 mg
Pt(COD)Cl2 (0.8 mmol, 1 eq.), 602 mg of 2,2,6,6-tetramethylheptane-3,5-
dione (5) (3.2 mmol, 4.0 eq.), 359 mg of KOtBu (3.2 mmol, 4.0 eq.) and
following General Procedure A in temperature and workup steps yielded
complex 12 as a yellow powder (164 mg, 36.2 %). M.p.: dec. >337 °C.
1H-NMR (CDCl3, 25 °C, 300 MHz): δ 7.95–7.66 (m, 1H, CHarom), 7.38–
7.23 (m, 1H, CHarom), 7.08–6.89 (m, 2H, CHarom), 5.75 (s, 1H, CHacac),
2.59 (s, 3H, CH3), 2.18 (s, 3H, CH3), 1.21 (s, 9H, CH3), 1.19 (s, 9H, CH3)
ppm. 13C-NMR (CDCl3, 25 °C, 75 MHz): δ 195.5 (CO), 194.7 (CO), 178.9
(NCS), 151.5 (Ci-Pt), 136.8 (Ci), 132.8 (CHarom), 128.9 (Ci), 125.4
(CHarom), 123.5 (Ci), 123.1 (CHarom), 113.3 (CHarom), 92.8 (CHarom), 41.7
(Ci), 41.3 (Ci), 28.6 (3C, CH3), 28.4 (3C, CH3), 14.1 (CH3), 12.7 (CH3)
ppm. 195Pt-NMR (65 MHz, 25 °C, CDCl3): δ -3320 ppm. MS (ESI+, m/z,
fragment): 567.3 (M+H)+. Anal. Calc. for C22H29NO2PtS: C, 46.63; H,
5.16; N, 2.47; S, 5.65%. Found: C, 46.76; H, 5.28; N, 2.35; S, 5.62%.
(SP-4-4)-[4,5-dimethyl-3-phenyl-κC’-1,3-thiazol-2-ylidene-κC]-[1,3-
diphenylpropane-1,3-dionato-κO,κO’]platinum(II) (13).
(SP-4-4)-[4,5-dimethyl-3-phenyl-κC’-1,3-thiazol-2-ylidene-κC]-[1,3-
bis(2,3,5,6-tetramethylphenyl)propane-1,3-dionato-κO,κO’]
platinum(II) (15). According to the General Procedure B 20 ml of dry 1,4-
dioxane were added to a mixture of 268 mg (0.8 mmol) N-phenyl-4,5-
dimethylthiazolium salt 1 and 102 mg of Ag2O (0.44 mmol, 0.55 eq.).
Stepwise addition of 299 mg Pt(COD)Cl2 (0.8 mmol, 1 eq.), 1.08 g 1,3-
bis(2,3,5,6-tetramethylphenyl)propane-1,3-dione (8) (3.2 mmol, 4.0 eq.)
and 359 mg of KOtBu (3.2 mmol, 4.0 eq.) and following General
Procedure B in temperature and workup steps yielded complex 15 as a
yellow powder (97 mg, 16.9 %). M.p.: dec. >317 °C. 1H-NMR (CDCl3,
25 °C, 300 MHz): δ 7.99–7.67 (m, 1H, CHarom), 7.51–7.31 (m, 1H,
CHarom), 7.12–6.98 (m, 2H, CHarom), 6.94 (d, J = 3.3 Hz, 2H, CHarom), 5.63
(s, 1H, CHacac), 2.70 (s, 3H, CH3), 2.39–2.10 (m, 27H) ppm. 13C-NMR
(CDCl3, 25 °C, 75 MHz): δ 187.1 (CO), 186.01 (CO), 177.9 (NCS), 151.4
(Ci-Pt), 142.5 (Ci), 142.4 (Ci), 136.9 (Ci), 133.7 (Ci), 133.6 (Ci), 133.2 (Ci),
133.1 (CHarom), 132.3 (Ci), 131.1 (CHarom), 131.0 (Ci), 129.8 (Ci), 129.7
(Ci), 128.9 (Ci), 127.4 (Ci), 125.6 (CHarom), 124.0 (CHarom), 123.6 (Ci),
This article is protected by copyright. All rights reserved.